A Fair Artificial Intelligence Research & Regulation (FAIRR) Bureau
Summary
Artificial intelligence (AI) is transforming our everyday reality, and it has the potential to save or to cost lives. Innovation is advancing at a breakneck pace, with technology developers engaging in de facto policy-setting through their decisions about the use of data and the embedded bias in their algorithms. Policymakers must keep up. Otherwise, by ceding decision-making authority to technology companies, we face the rising threat of becoming a technocracy. Given the potential benefits and threats of AI to US national security, economy, health, and beyond, a comprehensive and independent agency is needed to lead research, anticipate challenges posed by AI, and make policy recommendations in response. The Biden-Harris Administration should create the Fair Artificial Intelligence Research & Regulation (FAIRR) Bureau, which will bring together experts in technology, human behavior, and public policy from all sectors – public, private, nonprofit, and academic – to research and develop policies that enable the United States to leverage AI as a positive force for national security, economic growth, and equity. The FAIRR Bureau will adopt the interdisciplinary, evidence-based approach to AI regulation and policy needed to address this unprecedented challenge.
To better understand what might drive the way we live, learn, and work in 2050, we’re asking the community to share their expertise and thoughts about how key factors like research and development infrastructure and automation will shape the trajectory of the ecosystem.
Recognizing the power of the national transportation infrastructure expert community and its distributed expertise, ARPA-I took a different route that would instead bring the full collective brainpower to bear around appropriately ambitious ideas.
NIH needs to seriously invest in both the infrastructure and funding to undertake rigorous nutrition clinical trials, so that we can rapidly improve food and make progress on obesity.
Modernizing ClinicalTrials.gov will empower patients, oncologists, and others to better understand what trials are available, where they are available, and their up-to-date eligibility criteria, using standardized search categories to make them more easily discoverable.